The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular profiling of melanoma brain metastases (MBM) compared to primary cutaneous melanoma (CM).
 
Gino Kim In
Consulting or Advisory Role - Bristol-Myers Squibb
 
Kelsey Anne Poorman
Employment - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Michelle Saul
Employment - Caris Life Sciences
Research Funding - Caris Life Sciences
 
Steven O'Day
Honoraria - Agenus; Biothera; Bristol-Myers Squibb; ImaginAb; Merck; RadImmune
Consulting or Advisory Role - Agenus; Biothera; Bristol-Myers Squibb; ImaginAb; Merck; RadImmune
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Amgen (Inst); Biothera (Inst); Exicure (Inst); Genocea Biosciences (Inst); Incyte (Inst); Merck (Inst); Oncotherapeutics (Inst); Ultimovacs (Inst); Viralytics (Inst)
Travel, Accommodations, Expenses - Agenus; Bristol-Myers Squibb; Caris MPI; ImaginAb; Merck
 
Jeffrey M. Farma
Consulting or Advisory Role - Amgen; Castle Biosciences
Other Relationship - Delcath Systems
 
Steven Daveluy
Consulting or Advisory Role - Castle Biosciences
Speakers' Bureau - Abbvie
Research Funding - InflarxGmbH; Regeneron
 
Anthony J. Olszanski
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; EMD Serono; G1 Therapeutics; Merck; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); EMD Serono (Inst); Immunocore (Inst); Incyte (Inst); Kura Oncology (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst); Targovax (Inst)
Travel, Accommodations, Expenses - Takeda
 
Michael S. Gordon
Stock and Other Ownership Interests - Caremission; WCCT Global
Consulting or Advisory Role - Castle Biosciences; Deciphera; RedHill Biopharma; TRACON Pharma
Research Funding - Abbvie (Inst); Acetylon Pharmaceuticals (Inst); Aduro Biotech (Inst); Advaxis (Inst); Amgen (Inst); Amgen (Inst); Array BioPharma (Inst); BeiGene (Inst); BiolineRx (Inst); Calithera Biosciences (Inst); CanBas (Inst); Celgene (Inst); Celldex (Inst); Corcept Therapeutics (Inst); CytomX Therapeutics (Inst); Deciphera (Inst); Driver Group (Inst); Endocyte (Inst); ESSA (Inst); Five Prime Therapeutics (Inst); Fujifilm (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); Hengrui Therapeutics (Inst); Inanovate (Inst); Incyte (Inst); Lilly (Inst); Lilly/ImClone (Inst); MabVax (Inst); Macrogenics (Inst); MedImmune (Inst); Merck Serono (Inst); Merrimack (Inst); Millennium (Inst); Minneamrita Therapeutics (Inst); Nektar (Inst); Novartis (Inst); Novita Pharmaceuticals (Inst); OncoMed (Inst); Pfizer (Inst); Phoenix Biotech (Inst); Plexxikon (Inst); Proderm IQ (Inst); Samumed (Inst); Seagen (Inst); Sirtex Medical (Inst); Strategia Therapeutics (Inst); Syndax (Inst); SynDevRx (Inst); tesaro (Inst); Tokai Pharmaceuticals (Inst); Tolero Pharmaceuticals (Inst); Toray Industries (Inst); TRACON Pharma (Inst); Trovagene (Inst); Verastem (Inst)
Patents, Royalties, Other Intellectual Property - Patient on patient selection for Clinical Trials
 
Jacob Stephen Thomas
Travel, Accommodations, Expenses - eFFECTOR Therapeutics; Pfizer
 
Burton Larry Eisenberg
No Relationships to Disclose
 
Lawrence E. Flaherty
Consulting or Advisory Role - HUYA Bioscience International; Merck/Schering Plough
Travel, Accommodations, Expenses - Merck/Schering Plough
 
Geoffrey Thomas Gibney
Consulting or Advisory Role - Genentech/Roche; Genentech/Roche; Incyte; Newlink Genetics; Newlink Genetics; Novartis; Novartis; Novartis
Speakers' Bureau - Genentech/Roche; Merck
 
Michael B. Atkins
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Acceleron Pharma; Aduro Biotech; Agenus; Array BioPharma; Arrowhead Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Glactone Pharma; Immunocore; Iovance Biotherapeutics; Merck; Newlink Genetics/Pharmatech; Novartis; Oncolys BioPharma; Pfizer; Surface Oncology; Werewolf Pharma; X4 Pharma
Research Funding - Bristol-Myers Squibb (Inst)
 
Ari M. Vanderwalde
Honoraria - AstraZeneca
Consulting or Advisory Role - Bristol-Myers Squibb; Caris Life Sciences; Compugen; Genentech/Roche; Immunocore
Research Funding - Amgen (Inst); Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Polynoma (Inst); Replimune (Inst)